HSF1乙酰化降低其转录活性并增强糖脂毒性诱导的大鼠和人β细胞凋亡
本研究探讨热休克因子蛋白1(HSF1)在胰岛β细胞中的调控及其在细胞存活中的作用。糖脂毒性和毒胡萝卜素处理人胰岛和β细胞系后,HSF1乙酰化增强、与CBP相互作用增加,DNA结合活性下降,靶基因表达减少。恢复HSF1活性可防止糖脂毒性诱导的内质网应激和凋亡,但模拟组成性乙酰化的K80Q突变体失去保护作用。糖尿病GK大鼠胰岛中HSF1及其靶基因表达改变,提示该通路可能参与糖尿病病理生理并成为治疗干预靶点。
要点
- 糖脂毒性促进HSF1乙酰化并与CBP相互作用,抑制HSF1 DNA结合活性及靶基因表达。
- 恢复HSF1活性可防止糖脂毒性诱导的β细胞内质网应激和凋亡。
- 模拟组成性乙酰化的HSF1 K80Q突变体不能提供抗糖脂毒性保护。
核心结论
- HSF1抑制是糖脂毒性诱导β细胞凋亡所需的新机制。
- 恢复HSF1活性可能是维持功能性β细胞 mass 的新策略。
- 本研究支持HSF1/热休克蛋白靶向药物在糖尿病治疗中的治疗潜力。
研究设计与样本
- 将人胰岛和β细胞系暴露于糖脂毒性和毒胡萝卜素。
- 用凝胶迁移实验评估HSF1活性,用蛋白质印迹法检测HSF1乙酰化及与蛋白乙酰化酶CBP的相互作用。
- 检测糖尿病Goto-Kakizaki(GK)大鼠模型胰岛中HSF1及其经典靶基因的表达。
- 使用模拟HSF1组成性乙酰化和去乙酰化的突变体研究其效应。
主要发现
- 糖脂毒性促进HSF1乙酰化及与CBP的相互作用。
- 糖脂毒性诱导的HSF1乙酰化抑制HSF1 DNA结合活性并降低其靶基因表达。
- 在β细胞中恢复HSF1活性可防止糖脂毒性诱导的内质网应激和凋亡。
- 过表达模拟HSF1组成性乙酰化的K80Q突变体不能提供抗糖脂毒性保护。
- 糖尿病GK大鼠胰岛中HSF1及其靶基因表达发生改变。
临床怎么用
- 作者认为恢复HSF1活性可能代表维持功能性β细胞 mass 的新策略。
- 作者认为本研究支持HSF1/热休克蛋白靶向药物在糖尿病治疗中的治疗潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Heat shock factor protein 1 (HSF1) is a transcription factor that regulates the expression of key molecular chaperones, thereby orchestrating the cellular response to stress. This system was recently implicated in the control of insulin sensitivity and is therefore being scrutinised as a novel therapeutic avenue for type 2 diabetes. However, the regulation and biological actions of HSF1 in beta cells remain elusive. Herein, we sought to investigate the regulation of HSF1 in pancreatic beta cells and to study its potential role in cell survival. METHODS: We exposed human islets and beta cell lines to glucolipotoxicity and thapsigargin. HSF1 activity was evaluated by gel shift assay. HSF1 acetylation and interaction with the protein acetylase cAMP response element binding protein (CBP) were investigated by western blot. We measured the expression of HSF1 and its canonical targets in islets from Goto-Kakizaki (GK) rat models of diabetes and delineated the effects of HSF1 acetylation using mutants mimicking constitutive acetylation and deacetylation of the protein. RESULTS: Glucolipotoxicity promoted HSF1 acetylation and interaction with CBP. Glucolipotoxicity-induced HSF1 acetylation inhibited HSF1 DNA binding activity and decreased the expression of its target genes. Restoration of HSF1 activity in beta cells prevented glucolipotoxicity-induced endoplasmic reticulum stress and apoptosis. However, overexpression of a mutant protein (K80Q) mimicking constitutive acetylation of HSF1 failed to confer protection against glucolipotoxicity. Finally, we showed that expression of HSF1 and its target genes were altered in islets from diabetic GK rats, suggesting that this pathway could participate in the pathophysiology of diabetes and constitutes a potential site for therapeutic intervention. CONCLUSIONS/INTERPRETATION: Our results unravel a new mechanism by which HSF1 inhibition is required for glucolipotoxicity-induced beta cell apoptosis. Restoring HSF1 activity may represent a novel strategy for the maintenance of a functional beta cell mass. Our study supports the therapeutic potential of HSF1/heat shock protein-targeting agents in diabetes treatment.
引用
- Purwana I, Liu JJ, Portha B, et al. HSF1 acetylation decreases its transcriptional activity and enhances glucolipotoxicity-induced apoptosis in rat and human beta cells. Diabetologia. 2017. PMID: 28547133. doi:10.1007/s00125-017-4310-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。